The absence of statistical differences in the initial AML induction might attribute to imbalanced transfection efficacy of MSCV-MLL-AF9-IRES-YFP into Lin− cells, which comprised hematopoietic cells at different stages and possess uneven self-renewal capabilities. The gene discussed is MLLT3; the disease is acute myeloid leukemia.